Skip to main content

kelly barrett geisinger national

Program Leader, National Initiatives
Assistant Professor, Precision Health

Geisinger National Precision Health
155 Gibbs St., 4th floor
Rockville, MD 20850

Kelly Schiabor Barrett, PhD

Research interests

Kelly Schiabor Barrett, PhD, is Program Leader for National Initiatives and Assistant Professor of Precision Health for Geisinger National, in Maryland. She received a PhD in Genomics from UC Berkeley, bachelor’s degrees in biology and economics, and a certificate in genome sciences and policy from Duke University. Kelly is committed to making precision health a reality today, as well as developing creative, multidisciplinary methods to better understand the genome in the context of human health. 
Personal and population-based genetic information is transforming modern healthcare and the patient experience. Each day, more and more genomic sequence variants are linked to human health phenotypes—not only Mendelian diseases but also complex ones. While each variant’s validity and scope in the context of human health must be thoroughly vetted before moving from research to the practice of healthcare, there are many variants that have passed this test and can return valuable health information to healthy people.  

This healthcare transformation is happening today at Geisinger through the MyCode project. As part of the newly established Geisinger National team, Kelly is using the learnings from this successful community health program to help build a nationally scalable genetically-informed, patient-driven healthcare initiative. The Geisinger National team is rethinking all aspects of the precision health experience, including sample collection, sequencing, bioinformatics, variant calling, genetic counselling, and the continuing care models necessary to change population health and modern medicine. 

From a research perspective, Kelly is interested in better understanding the frequency and functional impact of human sequence variation using exome and, eventually, whole genome sequencing. For example, how does our understanding of rare and common variation change as we collect more complete genomic data for healthy individuals? What do these new learnings mean for modern medicine and preventative care? She is also exploring ways to use integrated electronic health record (EHR) data to guide our identification of causative variants in complex human disease and ultimately our understanding of the underlying biology of these conditions. 


Recent publications

  • Cinnamon S. Bloss, Kelly M. Schiabor, Nicholas J. Schork. Human behavioral informatics in genetic studies of neuropsychiatric disease: Multivariate profile-based analysis, Brain Research Bulletin, Volume 83, Issues 3–4, 2010, Pages 177-188, ISSN 0361-9230. Full text
  • Schiabor KM, Quan AS, Eisen MB (2014) Saccharomyces cerevisiae mitochondria are required for optimal attractiveness to Drosophila melanogaster. PLOS ONE 9(12): e113899. Full text


PhD, Genomics, UC Berkeley
BS, Biology, Economics, Duke University
Certificate, Genome Sciences, Duke University